Does extraction of cardiac implantable electronic devices improve outcome in patients with Staphylococcus aureus bacteraemia?

References

• Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, UK Clinical Infection Research Group, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis. 2011;11(3):208–222.
   PubMed Web of Science ®Google Scholar
• Nambiar K, Seifert H, Rieg S, International Staphylococcus aureus collaboration (ISAC) study group (with linked authorship to members in the Acknowledgements) and the ESCMID Study Group for Bloodstream Infections and Sepsis (ESGBIS), et al. Survival following Staphylococcus aureus bloodstream infection: a prospective multinational cohort study assessing the impact of place of care. J Infect. 2018;77(6):516–525.
   PubMed Web of Science ®Google Scholar
• Asgeirsson H, Thalme A, Weiland O. Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review. Infect Dis (Lond). 2018;50(3):175–192.
   PubMed Web of Science ®Google Scholar
• Blomstrom-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2019;14:515–549.
   Google Scholar
• Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503–e551.
   PubMed Web of Science ®Google Scholar
• Thwaites GE, Scarborough M, Szubert A, United Kingdom Clinical Infection Research Group (UKCIRG), et al. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10121):668–678.
   PubMed Web of Science ®Google Scholar
• Rieg S, Joost I, Weiss V, et al. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteremia – a post hoc analysis in 964 prospectively evaluated patients. Clin Microbiol Infect. 2016;8:30370–30376.
   Google Scholar
• Jacobsson G, Nasic S. Long-term outcome of invasive Staphylococcus aureus infections. Scand J Infect Dis. 2012;44(5):350–354.
   PubMed Web of Science ®Google Scholar
• Eskesen AN, Belle MA, Blomfeldt A. Predictors of one-year all-cause mortality and infection-related mortality in patients with Staphylococcus aureus bacteraemia. Infect Dis (Lond). 2018;50(10):743–748.
   PubMed Web of Science ®Google Scholar
• Annual Statistical Report 2018 Swedish ICD and Pacemaker Registry: Karolinska Hospital, Department of Cardiology; 2018.
   Google Scholar
• Tan EM, DeSimone DC, Sohail MR, et al. Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis. 2017;64(11):1516–1521.
   PubMed Web of Science ®Google Scholar
• Olsen T, Jorgensen OD, Nielsen JC, et al. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018) . Eur Heart J. 2019;40(23):1862–1869.
   PubMed Web of Science ®Google Scholar
• Yahav D, Yassin S, Shaked H, et al. Risk factors for long-term mortality of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2016;35(5):785–790.
   PubMed Web of Science ®Google Scholar
• Downey BC, Juselius WE, Pandian NG, et al. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin Electrophysiol. 2011;34(6):679–683.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, ESC Scientific Document Group, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–3128.
   PubMed Web of Science ®Google Scholar
• Diseases SSoI. Swedish guidelines on the management of infective endocarditis 2016 Swedish Society of Infectious Diseases. [cited 2020 Jul 22]. Available from: https://infektion.net/vardprogram/endokardit/2016
   Google Scholar
• Le Moing V, Alla F, Doco-Lecompte T, VIRSTA Study Group, et al. Staphylococcus aureus bloodstream infection and endocarditis – a prospective cohort study. PLoS One. 2015;10(5):e0127385.
   PubMed Web of Science ®Google Scholar
• Uslan DZ, Dowsley TF, Sohail MR, et al. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010;33(4):407–413.
   PubMed Web of Science ®Google Scholar
• Sohail MR, Palraj BR, Khalid S, et al. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015;8(1):137–144.
   PubMed Web of Science ®Google Scholar